$ACRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aclaris Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aclaris Therapeutics, Inc.. Get notifications about new insider transactions in Aclaris Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Option Exercise | M | 0.00 | 8,876 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Option Exercise | A | 0.00 | 8,876 | 0 | 8,876 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Buy | M | 0.00 | 8,876 | 0 | 9,376 | 500 to 9.4 K (+1,775.20 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | M | 0.00 | 8,876 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | A | 0.00 | 8,876 | 0 | 8,876 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | M | 0.00 | 8,876 | 0 | 16,558 | 7.7 K to 16.6 K (+115.54 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | M | 0.00 | 8,876 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | A | 0.00 | 8,876 | 0 | 8,876 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Buy | M | 0.00 | 8,876 | 0 | 8,876 | 0 to 8.9 K |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | GOWEN MAXINE | Director | Option Exercise | M | 0.00 | 4,438 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | GOWEN MAXINE | Director | Option Exercise | A | 0.00 | 4,438 | 0 | 4,438 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | GOWEN MAXINE | Director | Buy | M | 0.00 | 4,438 | 0 | 4,438 | 0 to 4.4 K |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 0.00 | 26,551 | 0 | 26,551 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 0.00 | 66,377 | 0 | 66,377 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 1.26 | 92,928 | 117,089 | 92,928 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 17,175 | 0 | 51,525 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 1.26 | 4,779 | 6,022 | 99,199 | 104 K to 99.2 K (-4.60 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 17,175 | 0 | 103,978 | 86.8 K to 104 K (+19.79 %) |
| Feb 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 10,800 | 0 | 21,600 | |
| Feb 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 1.28 | 3,675 | 4,704 | 928,903 | 932.6 K to 928.9 K (-0.39 %) |
| Feb 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 10,800 | 0 | 932,578 | 921.8 K to 932.6 K (+1.17 %) |
| Feb 04 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,875 | 0 | 7,750 | |
| Feb 04 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 1.28 | 1,308 | 1,674 | 169,367 | 170.7 K to 169.4 K (-0.77 %) |
| Feb 04 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 3,875 | 0 | 170,675 | 166.8 K to 170.7 K (+2.32 %) |
| Feb 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 3,875 | 0 | 7,750 | |
| Feb 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 1.28 | 1,318 | 1,687 | 86,803 | 88.1 K to 86.8 K (-1.50 %) |
| Feb 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 3,875 | 0 | 88,121 | 84.2 K to 88.1 K (+4.60 %) |
| Jan 09 2020 | ACRS | Aclaris Therapeuti ... | MILANO VINCENT | Director | Option Exercise | A | 1.85 | 22,000 | 40,700 | 22,000 | |
| Dec 20 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,075 | 0 | 0 | |
| Dec 20 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 1.81 | 277 | 501 | 84,246 | 84.5 K to 84.2 K (-0.33 %) |
| Dec 20 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,075 | 0 | 84,523 | 83.4 K to 84.5 K (+1.29 %) |
| Dec 18 2019 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 3,033 | 0 | 3,034 | |
| Dec 18 2019 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 1.80 | 782 | 1,408 | 919,596 | 920.4 K to 919.6 K (-0.08 %) |
| Dec 18 2019 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 3,033 | 0 | 920,378 | 917.3 K to 920.4 K (+0.33 %) |
| Dec 18 2019 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,300 | 0 | 1,300 | |
| Dec 18 2019 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 1.80 | 370 | 666 | 165,906 | 166.3 K to 165.9 K (-0.22 %) |
| Dec 18 2019 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,300 | 0 | 166,276 | 165 K to 166.3 K (+0.79 %) |
| Dec 18 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,733 | 0 | 1,734 | |
| Dec 18 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 1.80 | 497 | 895 | 83,448 | 83.9 K to 83.4 K (-0.59 %) |
| Dec 18 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,733 | 0 | 83,945 | 82.2 K to 83.9 K (+2.11 %) |
| Oct 31 2019 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 175,000 | 0 | 175,000 | |
| Jul 03 2019 | ACRS | Aclaris Therapeuti ... | GOWEN MAXINE | Director | Option Exercise | A | 2.34 | 16,000 | 37,440 | 16,000 | |
| Jul 03 2019 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 6,000 | 0 | 18,000 | |
| Jul 03 2019 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Payment of Exercise | F | 2.34 | 1,648 | 3,856 | 4,352 | 6 K to 4.4 K (-27.47 %) |
| Jul 03 2019 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Buy | M | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Jul 01 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 2.69 | 590,801 | 1,589,668 | 3,159,165 | 3.7 M to 3.2 M (-15.75 %) |
| Jul 01 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 2.69 | 108,674 | 292,409 | 964,101 | 1.1 M to 964.1 K (-10.13 %) |
| Jun 26 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 4.50 | 1,352 | 6,086 | 3,749,966 | 3.8 M to 3.7 M (-0.04 %) |
| Jun 26 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 4.50 | 352 | 1,585 | 1,072,775 | 1.1 M to 1.1 M (-0.03 %) |
| Jun 25 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 4.51 | 40,850 | 184,189 | 3,751,318 | 3.8 M to 3.8 M (-1.08 %) |
| Jun 25 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 4.51 | 10,634 | 47,948 | 1,073,127 | 1.1 M to 1.1 M (-0.98 %) |
| Jun 25 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 4.52 | 50,177 | 226,925 | 3,792,168 | 3.8 M to 3.8 M (-1.31 %) |
| Jun 25 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 4.52 | 13,063 | 59,077 | 1,083,761 | 1.1 M to 1.1 M (-1.19 %) |
| Jun 25 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 4.62 | 269,402 | 1,243,398 | 3,842,345 | 4.1 M to 3.8 M (-6.55 %) |
| Jun 25 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 4.62 | 70,135 | 323,701 | 1,096,824 | 1.2 M to 1.1 M (-6.01 %) |
| Jun 10 2019 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | A | 0.00 | 7,333 | 0 | 7,333 | |
| Jun 10 2019 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | A | 0.00 | 7,333 | 0 | 7,333 | |
| Jun 10 2019 | ACRS | Aclaris Therapeuti ... | Humphries William D. | Director | Option Exercise | A | 0.00 | 7,333 | 0 | 7,333 | |
| Jun 10 2019 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | A | 0.00 | 7,333 | 0 | 7,333 | |
| Jun 10 2019 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Option Exercise | A | 0.00 | 7,333 | 0 | 7,333 | |
| Jun 10 2019 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | A | 0.00 | 7,333 | 0 | 7,333 | |
| Jun 10 2019 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Option Exercise | A | 0.00 | 7,333 | 0 | 7,333 | |
| May 13 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 6.05 | 71,869 | 434,750 | 1,166,959 | 1.2 M to 1.2 M (-5.80 %) |
| May 13 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 6.05 | 108,696 | 657,524 | 4,111,747 | 4.2 M to 4.1 M (-2.58 %) |
| May 13 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 6.16 | 172,800 | 1,064,016 | 1,238,828 | 1.4 M to 1.2 M (-12.24 %) |
| May 13 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Sell | S | 6.16 | 261,345 | 1,609,232 | 4,220,443 | 4.5 M to 4.2 M (-5.83 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 10,800 | 0 | 32,400 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 6.96 | 3,579 | 24,910 | 917,345 | 920.9 K to 917.3 K (-0.39 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 10,800 | 0 | 920,924 | 910.1 K to 920.9 K (+1.19 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 3,400 | 0 | 10,200 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 6.96 | 1,114 | 7,753 | 141,729 | 142.8 K to 141.7 K (-0.78 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 3,400 | 0 | 142,843 | 139.4 K to 142.8 K (+2.44 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,875 | 0 | 11,625 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 6.96 | 1,308 | 9,104 | 272,047 | 273.4 K to 272 K (-0.48 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 3,875 | 0 | 273,355 | 269.5 K to 273.4 K (+1.44 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,875 | 0 | 11,625 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 6.96 | 1,308 | 9,104 | 164,976 | 166.3 K to 165 K (-0.79 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 3,875 | 0 | 166,284 | 162.4 K to 166.3 K (+2.39 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,875 | 0 | 11,625 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Payment of Exercise | F | 6.96 | 1,308 | 9,104 | 10,582 | 11.9 K to 10.6 K (-11.00 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Buy | M | 0.00 | 3,875 | 0 | 11,890 | 8 K to 11.9 K (+48.35 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 3,875 | 0 | 11,625 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 6.96 | 1,308 | 9,104 | 82,212 | 83.5 K to 82.2 K (-1.57 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 3,875 | 0 | 83,520 | 79.6 K to 83.5 K (+4.87 %) |
| Jan 18 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.93 | 1 | 7 | 1 | |
| Jan 18 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.97 | 1 | 7 | 1 | |
| Jan 18 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 7.00 | 1 | 7 | 1 | |
| Jan 02 2019 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 7.00 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.89 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.86 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.92 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.89 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.86 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.92 | 1 | 7 | 1 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.95 | 1 | 7 | 1 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.84 | 1 | 7 | 1 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.91 | 1 | 7 | 1 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,250 | 0 | 1,250 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 6.30 | 356 | 2,243 | 162,409 | 162.8 K to 162.4 K (-0.22 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,250 | 0 | 162,765 | 161.5 K to 162.8 K (+0.77 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 2,925 | 0 | 2,925 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 6.30 | 833 | 5,248 | 910,124 | 911 K to 910.1 K (-0.09 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 2,925 | 0 | 910,957 | 908 K to 911 K (+0.32 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,450 | 0 | 1,450 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 6.30 | 412 | 2,596 | 269,480 | 269.9 K to 269.5 K (-0.15 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,450 | 0 | 269,892 | 268.4 K to 269.9 K (+0.54 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,750 | 0 | 1,750 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Payment of Exercise | F | 6.30 | 498 | 3,137 | 8,015 | 8.5 K to 8 K (-5.85 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Buy | M | 0.00 | 1,750 | 0 | 8,513 | 6.8 K to 8.5 K (+25.88 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 1,625 | 0 | 1,625 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 6.30 | 446 | 2,810 | 139,443 | 139.9 K to 139.4 K (-0.32 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 1,625 | 0 | 139,889 | 138.3 K to 139.9 K (+1.18 %) |
| Dec 20 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,075 | 0 | 1,075 | |
| Dec 20 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 6.30 | 306 | 1,928 | 79,645 | 80 K to 79.6 K (-0.38 %) |
| Dec 20 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,075 | 0 | 79,951 | 78.9 K to 80 K (+1.36 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 3,033 | 0 | 6,067 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 3,033 | 0 | 6,067 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 7.31 | 863 | 6,309 | 908,032 | 908.9 K to 908 K (-0.09 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 7.31 | 863 | 6,309 | 908,032 | 908.9 K to 908 K (-0.09 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 3,033 | 0 | 908,895 | 905.9 K to 908.9 K (+0.33 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 3,033 | 0 | 908,895 | 905.9 K to 908.9 K (+0.33 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 7.31 | 370 | 2,705 | 161,515 | 161.9 K to 161.5 K (-0.23 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 7.31 | 370 | 2,705 | 161,515 | 161.9 K to 161.5 K (-0.23 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,300 | 0 | 161,885 | 160.6 K to 161.9 K (+0.81 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,300 | 0 | 161,885 | 160.6 K to 161.9 K (+0.81 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 7.31 | 370 | 2,705 | 268,442 | 268.8 K to 268.4 K (-0.14 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 7.31 | 370 | 2,705 | 268,442 | 268.8 K to 268.4 K (-0.14 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,300 | 0 | 268,812 | 267.5 K to 268.8 K (+0.49 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,300 | 0 | 268,812 | 267.5 K to 268.8 K (+0.49 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,733 | 0 | 3,467 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,733 | 0 | 3,467 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 7.31 | 493 | 3,604 | 78,876 | 79.4 K to 78.9 K (-0.62 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 7.31 | 493 | 3,604 | 78,876 | 79.4 K to 78.9 K (-0.62 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,733 | 0 | 79,369 | 77.6 K to 79.4 K (+2.23 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,733 | 0 | 79,369 | 77.6 K to 79.4 K (+2.23 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 7.31 | 357 | 2,610 | 138,264 | 138.6 K to 138.3 K (-0.26 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 7.31 | 357 | 2,610 | 138,264 | 138.6 K to 138.3 K (-0.26 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 1,300 | 0 | 138,621 | 137.3 K to 138.6 K (+0.95 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 1,300 | 0 | 138,621 | 137.3 K to 138.6 K (+0.95 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,013 | 0 | 2,025 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Payment of Exercise | F | 7.31 | 288 | 2,105 | 6,763 | 7.1 K to 6.8 K (-4.08 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,013 | 0 | 2,025 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Buy | M | 0.00 | 1,013 | 0 | 7,051 | 6 K to 7.1 K (+16.78 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Payment of Exercise | F | 7.31 | 288 | 2,105 | 6,763 | 7.1 K to 6.8 K (-4.08 %) |